1. Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis

   de Jong, M. A., Petrykiv, S. I., Laverman, G. D., van Herwaarden, A. E., de Zeeuw, D., Bakker, S. J. L., Heerspink, H. J. L. & de Borst, M. H. 7-Jan-2019 In : Clinical Journal of the American Society of Nephrology. 14, 1, 8 p.

   Research output: Contribution to journal › Article

2. Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

   de Zeeuw, D., Renfurm, R. W., Bakris, G., Rossing, P., Perkovic, V., Hou, F. F., Nangaku, M., Sharma, K., Heerspink, H. J. L., Garcia-Hernandez, A. & Larsson, T. E. Dec-2018 In : Lancet Diabetes & Endocrinology. 6, 12, p. 925-933 9 p.

   Research output: Contribution to journal › Article

3. Evaluation of Surrogate End Points for Progression to ESKD: Necessary and Challenging

   Inker, L. A. & Heerspink, H. L. Dec-2018 In : American Journal of Kidney Diseases. 72, 6, p. 771-773 3 p.

   Research output: Contribution to journal › Editorial

4. Biomarkers for improved diagnosis and prognosis of chronic kidney disease

   Heerspink, H. J., de Zeeuw, D., Datema, R. & Woloszczuk, W. 18-Sep-2014 15-Mar-2013

   Research output: Patent

5. Baseline characteristics and enrichment results from the SONAR trial

   Heerspink, H. J. L., Andress, D. L., Bakris, G., Brennan, J. J., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J., Perkovic, V., Tobe, S., Wigderson, M., Yi, T., Parving, H-H. & de Zeeuw, D. Aug-2018 In : Diabetes obesity & metabolism. 20, 8, p. 1829-1835 7 p.

   Research output: Contribution to journal › Article

View all (236) »